Trials / Available
AvailableNCT05650476
Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Pfizer · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Provide pre-approval single-patient Expanded Access (Compassionate Use) of talazoparib for patients with metastatic castration-resistant prostate cancer.
Detailed description
In Expanded Access, treating physicians are the Sponsors.. Expanded Access requests from treating physicians may be submitted at www.pfizercares.com; availability will depend on location/country.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Talazoparib | capsules |
Timeline
- First posted
- 2022-12-14
- Last updated
- 2025-06-12
Source: ClinicalTrials.gov record NCT05650476. Inclusion in this directory is not an endorsement.